Gabriel Rinnerthaler

Gabriel Rinnerthaler is a Clinical Professor in the Department of Internal Medicine III at Paracelsus Medical University, specializing in Hematology, Medical Oncology, and Oncologic Center operations. His research focuses on breast cancer treatment, clinical trial methodologies, and the application of molecular diagnostics in oncology. Dr. Rinnerthaler has contributed to over 100 peer-reviewed publications and led/co-led multiple research projects, including studies on breast cancer screening efficacy in Salzburg and the efficacy of electrotherapy for chemotherapy-induced neuropathy.

• Key Projects:
  • Evaluated high-tone therapy for chemotherapy-induced peripheral neuropathy (HIT-CIPN project, 2019–2021).
  • Conducted analyses of ctDNA for tumor burden monitoring in head and neck cancer (2017).
• Research Themes:
  • Breast cancer screening and treatment outcomes.
  • Novel therapeutic approaches for HER2-positive breast cancer.
  • Molecular diagnostics using ctDNA and next-generation sequencing.
• Professional Contributions:
  • Organized the OeGHO Frühjahrestagung 2015 conference.
  • Co-supervised a thesis on androgen receptor expression in premenopausal breast cancer patients.

His work bridges clinical oncology with translational research, emphasizing patient-centered outcomes and innovative diagnostic tools.